DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer
about
sameAs
Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesisdCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial.Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arrays.Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progressionHigh levels of cleaved caspase-3 in colorectal tumour stroma predict good survival.Decoy receptor 3 is a prognostic factor in renal cell cancerDcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.Death decoy receptor overexpression and increased malignancy risk in colorectal cancer.siRNA targeting decoy receptor 3 enhances the sensitivity of gastric carcinoma cells to 5-fluorouracil.Two different docetaxel resistant MCF-7 sublines exhibited different gene expression pattern.Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.Response: Decoy receptor 3 (DcR3), a pleiotropic immunomodulator.
P2860
Q28300434-7DDB0DCC-5F2C-43AC-A484-42913DEAE463Q33727842-C5F9A789-1991-49BE-8F03-53B47DE4348CQ33741891-1A80694E-3E74-46D7-8F4F-139DC8EC5BCAQ36615251-9FA15326-3731-4990-AA9C-892B55805E40Q36896177-65E30CC4-44F0-43D8-A05B-CAF0F68AD1D3Q36897759-644F18EB-4F47-47E1-94A9-DFEC7021D4A8Q37335202-B9889A9D-4974-474D-B29A-02E7E4324A3DQ37708062-B1408290-B2EE-4335-8E11-B9F73EA8389FQ39238717-2F2712B2-5938-4212-829A-640C48166784Q39514723-7A8CE858-FDA1-4B9C-A263-3755B37E2EBAQ40582077-ECEE9983-9DE1-4648-B345-75B05526C67BQ45384023-CB39A671-21EA-4DF2-9F62-C20917527487Q55549466-E24BAA0D-2A14-4C6F-B8D9-8C13F0C3761D
P2860
DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@ast
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@en
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@nl
type
label
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@ast
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@en
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@nl
prefLabel
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@ast
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@en
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@nl
P2093
P2860
P356
P1476
DCR3 locus is a predictive mar ...... motherapy in colorectal cancer
@en
P2093
Christoph Rochlitz
Felix Bachmann
Gabriele Mild
Jean-Louis Boulay
Jürgen Reuter
Katharina Glatz
Luigi Terracciano
Richard Herrmann
Urban Laffer
P2860
P356
10.1002/IJC.10711
P407
P577
2002-11-20T00:00:00Z